Freight, duty, and clearing turn a quoted price into a real cost that is often far higher. Here is how to fold all of it into stock valuation, so what you charge is built on what you paid.
The supplier quotes a price for a box of reagents, and that price feels like the cost. It is not. By the time the box reaches the laboratory shelf, freight has been paid, duty has been charged, a clearing agent has taken a fee, and handling has added more. A reagent quoted at one figure may have cost a third more to land. Yet in most facilities, stock is valued at the supplier’s price, because that is the number on the invoice and the only one that made it onto the books. The freight, the duty, the clearing, all of it lands somewhere else, in a bank statement or a separate ledger, disconnected from the item it actually paid for.
When the true cost of a reagent is not on the books, everything downstream is built on a number that is too low. The cost of goods sold posted when the reagent is consumed understates what the test actually cost to run. The margin on a service looks healthier than it is. A price set to cover cost quietly fails to cover it, because the cost it was set against was only part of the real one. None of this is visible until the year-end numbers do not add up, and by then the cause is buried in months of disconnected charges.
The true cost of an imported item scatters for ordinary reasons.
The common cause is that the goods and the costs of getting them here arrive on different documents and are recorded in different places. When the freight invoice and the goods invoice never meet, the stock record keeps the cheaper of the two figures, and the real cost is lost.
Veona Procurement brings the scattered costs back to the item they belong to. When goods are received, freight, duty, clearing, and handling are apportioned across the received items as landed cost, so stock is valued at what it actually cost to land, not just what the supplier charged. A box quoted at one figure carries its full true cost on the books, with the freight and duty folded in. Because that landed value feeds the weighted-average valuation of the stock, the cost of goods sold posted when a reagent or consumable is drawn reflects the real cost of using it.
The price on the invoice is the beginning of the cost, not the end of it. Landed cost is the difference between knowing what a reagent really costs you and guessing.
The apportioning is the quiet but essential part. A single freight charge covering several items is spread across them in proportion, so each item carries its fair share of the cost of bringing the whole shipment in. The result is a stock valuation that is honest at the level of the individual item, which is the only level at which cost of goods sold can be accurate.
A reagent valued at its true landed cost changes what the hospital can see. The margin on a test is real, because the cost it is measured against includes everything that was paid to make the test possible. A price can be set to genuinely cover cost, because the cost is known in full. And the year-end numbers reconcile, because the freight and duty were never left orphaned in a side ledger; they were folded into the items they paid for and flowed into the cost of goods sold when those items were used. This honesty depends on the same unbroken chain from requisition to payment that holds the rest of buying together, with the goods receipt as the point where the landed cost attaches.
For a facility that imports a meaningful share of its reagents and consumables, landed cost is not an accounting nicety, it is the difference between knowing and not knowing whether the lab makes money. In Nigeria, freight, customs duty, and clearing can add a substantial fraction to the quoted price, and exchange-rate movement makes the gap between quoted and landed cost wider still. A hospital that values stock at the supplier’s price alone is systematically understating its costs and overstating its margins, and pricing its services on a fiction. Folding the real cost of importing into stock valuation lets a Nigerian hospital price for survival rather than for a number that was never the true one. Paired with a three-way match that protects what you pay the supplier, it means both halves of the cost are under control: what you pay, and what it really cost to land.
See freight and duty apportioned across a receipt so a reagent carries its true cost on the books. Book a demo and we will show you a landed-cost calculation end to end.
Most hospitals buy in fragments: a requisition here, an order there, an invoice that surfaces weeks later. Here is how to keep the whole cycle on one chain, so nothing falls between the steps.
Every hospital has paid an invoice it could not fully verify. Here is how matching the bill against the order and the delivery, before payment, closes the gap where overpayments live.
A quote in an email and an order on a phone call leave no trail. Here is how to evidence what you compared and committed, with the order wired to stock and the ledger from the start.
We will tailor a demo to how your hospital, clinic, or lab actually runs, offline behaviour, payments, reporting, and all.